Development of linagliptin ph sensitive polymeric nanoparticles using quality by design approach for the treatment of diabetes mellitus

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-FDP-030
• By: VENI, D. Krishna (JSS College of Pharmacy, Pharmaceutics, Mysuru, India)
• Co-author(s): D. Krishna Veni
  N. Vishal Gupta
  
• Abstract:

  Background

  Linagliptin is a DPP-4 Inhibitor used in the treatment of Type II Diabetes. One of the major drawbacks of this drug was found to be degradation in a gastric environment which lead to low bioavailability. In this study to overcome this challenge i have developed a new drug delivery and formulated as Polymeric Nanoparticles (PNP’s) to..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login